3P is a successful life sciences engineering and automation company, helping multi-national customers to develop, produce and commercialise new products. We offer a powerful combination of device development and customised automation skills and methodologies to help customers develop new products not just for manufacture, but for successful commercialisation and profitability in production. Experts in powder and liquid fill-finish, device assembly and testing, we also specialise in advanced manufacturing technologies such as 3D printing, high-flexibility manufacturing and solutions for personalised medicine dispensing and filling. As reflected in our name, we deliver Product, Process and Production solutions across the Life Sciences sector
Adare Pharmaceuticals is a global specialty CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare’s propriety technology platforms specialize in ODT, taste masking and customized drug release.
With over 30 years of proven legacy, Adare has successfully developed and manufactured more than 40 products sold by partners in more than 100 countries globally.
Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with more than 80 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.
For pharma customers worldwide, Aptar Pharma is the go-to drug delivery expert, providing innovative drug delivery systems, services and active packaging solutions across the widest range of delivery routes, including nasal, pulmonary, ophthalmic, dermal and injectables.
Aptar Pharma Services provide early stage to commercialization support to accelerate and derisk the development journey. With a strong focus on innovation, Aptar Pharma is leading the way in developing connected devices to deliver digital medicines. With a global manufacturing footprint of 14 GMP sites, Aptar Pharma provides security-of-supply and local support to customers. Aptar Pharma is part of AptarGroup, Inc. (NYSE:ATR).
Arcinova is a UK-based Custom Research and Development Organisation (CRDO) serving the global pharmaceutical and biotechnology communities.
From our single 15,000m2 facility, which has benefited from more than 36 years of investment as a key R&D centre for Sanofi and Covance, we can support our clients’ needs with a wide range of services such as: drug substance development and manufacturing (including GMP, [14C]-labelled products and high potents), material sciences, formulation and drug product manufacturing.
We can manufacture both drug substance and drug products from grams to multi-kilo scale.
We also offer supporting analytical services including, investigations and development of QC specifications, microbiological and stability testing as well as a regulatory CMC dossier writing service.
Finally, our experienced bioanalytical team can develop, validate and implement bioanalytical assays for small and large molecule drugs, generics and biomarkers to support both clinical and non-clinical studies.
We are Ardena, a reputable contract partner delivering drug development, manufacturing, logistics and (bio)analytical services to pharmaceutical customers globally. In parallel, we work with you to compile your regulatory dossier and to fast track your product towards compliance. Every day, we guide companies through the hurdles and challenges of drug development. Our integrated service offering helps to streamline the drug's progress to clinic and beyond. Ardena is your one source contractor for the chemical and pharmaceutical development of your valued compounds. In parallel, we provide you with full product analytical and bioanalytical support during development. Our dossier-centric approach makes a difference. We work with you to compile your regulatory dossier in parallel with drug development, saving you time, identifying hurdles and fast-tracking your product to compliance. We are experts in writing and formatting supporting CMC documentation.
Asahi Kasei is a highly diversified Japanese supplier of high-performance materials for various industries, including automotive, energy, electronics, housing and health care. In the fields of pharma- and nutraceuticals, we offer functional excipients. For many decades Asahi Kasei stands for quality, reliability and performance and is dedicated to “Creating for Tomorrow”.
Our key product is Ceolus, functional grades of microcrystalline cellulose (MCC) with outstanding compactability and flowability due to a special particle structure. This allows for avoiding typical formulation challenges like tablet mass segregation, capping, slow/fast disintegration, low tablet hardness or the changing of the API structure. Celphere, Asahi Kasei’s MCC spherical cores allow the combination of incompatible APIs in one tablet, achieve different release profiles and improve the acceptability of products. Special grades of our pregelatinized starch PC-10 can be applied for the protection of moisture sensitive APIs in the formulation.
Our functional excipients prove to be solutions to our customer’s daily challenges
Bachem provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. The group has a global reach with more experience and know-how than any other company in the industry. Bachem shows total commitment to quality, innovation and partnership.
Bachem. Pioneering Partner for Peptides
Focusing On Your Formulation Needs
BASF produces excipients and active ingredients of outstanding quality and performance. With our unique expertise in polymer chemistry, our research & development capabilities and our clear commitment to developing excipients, BASF has continuously created solutions that contribute to your success and to more efficient pharmaceuticals. We deliver value added functional solutions to your formulation challenges by leveraging our expertise in delivery systems and related technologies. Our team of experienced industry specialists support you in developing effective, reliable formulations – giving you a vital advantage in a highly competitive market.
Our Platforms – Your Access To BASFs Solution Offer
BASF has been committed to the pharmaceutical industry since we introduced our original Kollidon® in the early 20th century. Since then we have continuously expanded our solution offer. Today we solve unmet formulation needs and offer intelligent solutions for today and tomorrow's challenges in drug formulation. Our four dedicated solution platforms based on current pharmaceutical market needs help you to find what you are looking for – faster than ever before. We can help with formulation challenges related to Instant and Modified Release, Solubilization, Skin Delivery, Softgels and Biologic Solutions
BDD is a specialist pharmaceutical development company providing expertise across all areas of drug delivery. Our service, customised to our clients individual needs, is inclusive of project design, optimal formulation development and lean clinical evaluation.
Our patented, time release technology - OralogiK™ provides unrivalled control of drug release in vivo – delivery at the right place, at the right time.
OralogiK™ enables the delivery of single, multi-dose or drug combinations at pre-determined times post dose. Benefits include:
galenIQ™ - The filler-binder excipient that makes medicine taste better
BENEO, a division of the Südzucker Group, offers galenIQTM (Isomalt Ph.Eur., BP, USP-NF, JP), which is a water-soluble pharmaceutical excipient filler-binder.
galenIQ™ combines a multitude of outstanding characteristics, suitable for a wide range of pharmaceutical applications. In fact, it also has a sweetness and taste profile that is very similar to sucrose and therefore it is frequently used to improve the palatability of bitter-tasting active pharmaceutical ingredients (APIs), plant extracts and probiotics. galenIQ™ is non-cariogenic and shows a low glycaemic index which makes it the optimal choice for the formulation of a broad variety of dosage forms, such as chewable tablets, compressed lozenges, oro-dispersible mini-tablets, effervescents, sachets, and cough syrups.
BENEO is a member of the International Pharmaceutical Excipients Council (IPEC) and produces galenIQ™ under GMP conditions for pharmaceutical products.
Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology-critical issues for clients worldwide. For more than 50 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies.
The team of more than 850 staff, including engineers, scientists, mathematicians and designers have an unparalleled track record in creating medical technology solutions that disrupt markets and revolutionize healthcare. These range from parenteral delivery devices such as pens, autoinjectors, patch pumps and large volume injectors through to medical implants and surgical drug delivery systems. The team has also pioneered high functionality, user-centred electromechanical devices combining drug delivery with wireless connectivity and eHealth service solutions to enable patient engagement and adherence.
With offices in Cambridge (UK), Boston (USA) and Singapore, we have supported many of the market-leading biotech, pharmaceuticals and medical robotics companies.
Cambridge Design Partnership is a leading product and technology innovation partner with offices in Cambridge, UK and Raleigh NC, USA. We are experienced in drug delivery device design, development, prototype and short-run manufacturing for some of the world’s largest companies. Our experts in engineering, human factors and industrial design are able to take combination products through a full design cycle and submission, to enable you to launch a product that is customer focused and commercially effective. Certified to ISO 13485/9001.
Captisol is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Captisol was invented and initially developed by scientists in the laboratories of Dr. Valentino Stella, University Distinguished Professor at the University of Kansas’ Higuchi Biosciences Center for specific use in drug development and formulation. This unique technology has enabled several FDA-approved products, including Amgen’s Kyprolis®, Baxter International’s Nexterone®, Spectrum’s EVOMELA® and Melinta Therapeutics’ Baxdela™. There are many Captisol-enabled products currently in various stages of development.
CAS, a division of the American Chemical Society specializing in scientific information solutions, partners with R&D organizations globally to provide actionable insights that help them plan, innovate, protect their innovations, and predict how new markets and opportunities will evolve. Scientific researchers, patent professionals and business leaders around the world across commercial, academic and government sectors rely on our solutions and services to advise discovery and strategy. Leverage our unparalleled content, specialized technology, and unmatched human expertise to customize solutions that will give your organization an information advantage. With more than 110 years' experience, no one knows more about scientific information than CAS.
Credence MedSystems is an innovator in injectable drug delivery devices, offering our pharma partners a simplified path to commercialization of a best-in-class delivery system. The Companion Safety Syringe System was born from Credence’s philosophy of Innovation Without Change, allowing our customers to impress and protect their end users while preserving their existing processes, sourcing strategies and preferred primary package components. The Companion is available in luer needle, staked needle and dual chamber reconstitution configurations. The user performs the injection, receives end-of-dose cues and then the needle automatically retracts into the syringe, preventing reuse.
The Credence device platform also includes the Credence Connect™ Auto-Sensing Injection System, which incorporates automatic real-time monitoring of critical injection data into a reusable ergonomic finger grip. The Connect links to the Credence App on a smart phone and provides a comfortable grip that enhances the usability of any syringe while measuring and transmitting injection progress in real time
Established in 1925, Croda is the name behind high performance ingredients and technologies in some of the world’s biggest and most successful brands: creating, making and selling speciality chemicals that are relied on by industries and consumers everywhere. They have a network of over 4,500 passionate and committed employees, working together as one global team across manufacturing sites and offices in 38 countries. Within the Health Care market, Croda offers high purity pharmaceutical excipients, highly performing vaccine adjuvants and in-house formulation expertise, making them the ideal solutions provider with whom to navigate drug and vaccine formulation challenges. Their product portfolio is proven to solubilise, stabilise and deliver the most challenging of active pharmaceutical ingredients, while high investment in GMP and multi-site EXCiPACT accreditation demonstrates confidence in both excipient quality and supply chain security.
Crux is a product development consultancy serving the pharmaceutical industry with a fully integrated service wrapped around solid technical knowledge. Our highly experienced technical team consists of designers, engineers, human-factors experts, electronics and software specialists who champion evidence-based problem-solving. We couple this scientific approach with world-class facilities & equipment to develop device solutions that perform in the real world.
CycloLab is a private SME with the focus on cyclodextrin research and development for over 30 years focusing on pharmaceutical, cosmetic and food industry, agrochemical, environmental and analytical applications. Our company produces sulfobutylether beta-cyclodextrin (SBECD, DexolveTM) under cGMP conditions based on an FDA-approved DMF. CycloLab is also a contract research organization for cyclodextrin related formulation development, optimization, characterization, as well as custom synthesis of cyclodextrins. A versatile analytical background is in place to support our R&D and cGMP production related activities including method development, validation, stability studies for formulation ingredients and APIs such as Sugammadex.
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global health care world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our health care offering and its three pillars Bio Care, Pharma Care and Med Care, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient’s safety and improve patients’ lives.
DFE Pharma is the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation. Our portfolio consists of filler/binders (Lactose, Microcrystalline Cellulose, Starches), superdisintegrants (Croscarmellose Sodium and Sodium Starch Glycolate) and carriers for inhalation (Lactose). Please visit dfepharma.com
Emergo by UL’s Human Factors Research & Design team helps create products that deliver a great user experience. Human factors examines the relationship between humans and the systems they use, focusing on improving efficiency and ease of use with the goal of reducing errors. Our human factors research and design experts based in the US, Japan, and Europe can help you develop safer, more effective products and reduce regulatory risk.
Eurofins CDMO is a leading global Contract Development and Manufacturing Organization (CDMO) that provides clients with Active Pharmaceutical Ingredients (APIs)/Drug Substance and Drug Product development for biologicals and small molecules. Science is our foundation and allows us to support small and major biopharmaceutical companies achieving their pre-clinical and clinical milestones on time.
We are experts in breakthrough technologies for API development, highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs…).
Our services: API/DS Development, Solid State R&D, Preformulation, Formulation Development, GMP Manufacturing, Clinical Packaging and Logistics, CMC Regulatory Support.
Our highly-qualified project management team will propose a complete drug development strategy. Frequent communication through one single point of contact, our team's flexibility, troubleshooting mindset, customized solutions will help speed up the drug development process. Operating under strict quality procedures, Eurofins CDMO is accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and Health Canada.
Foster Delivery Science focuses solely on Hot Melt Extrusion and extrusion processes to blend client API’s with polymers for several possible purposes: Solubility and bioavailability enhancement; create local delivery solutions such as drug loaded films, implants and fibers; create delivery or release profiles; and capture the powerful mixing capabilities of twin screw extruders. Operating from our new GMP facility 75 minutes from Boston in CT, we provide formulation development services, scale up, clinical trial material and ready for GMP manufacturing.
Glatt Pharmaceutical Services develops solid pharmaceutical dosage forms with focus on multiparticulate systems, such as pellets, granules, tablets and capsules. The service portfolio covers the full range from feasibility studies and the formula-tion development over the production of clinical samples up to the bulk manufacturing of pharmaceuticals. The storage, commissioning, as well as the distribution organization of clinical samples and pharmaceuticals for market supply round off the service portfolio. In this sector, Pharmaceutical Services also offers additional logistic services for import, export and cold chain management.
As a global materials science company, Gore collaborates with pharmaceutical companies to design materials-based solutions that fit their requirements for product purity, process effectiveness and device performance. Our newest innovation, the GORE ImproJect Plunger for pre-filled syringes protects sensitive biologics from silicone-induced particle formation and protein aggregation since Gore has eliminated the need for silicone in both the plunger and barrel.
Halo Labs knows particles. The HORIZON, our flagship product, detects, counts and characterizes subvisible particles. A simple, plate-based approach enables low-volume (25 µL), high-throughput (96 samples) particle imaging and analysis at any stage of the biologics workflow from developability assessment through formulation and quality control.
Hovione offers customized services and innovative solutions from drug substance to drug product, with all activities performed at the same site. Hovione provides a fully integrated service for clinical and small commercial scale complex drug product development and manufacturing as well as formulation development for highly sophisticated inhalation and other formulations both for small molecules and biologics. As the Leader in Commercial Spray Drying, Hovione can handle projects from early-phase development to commercial and accelerates your time to market. Our particle engineering technologies can address challenges in solubility enhancement, lung delivery, modified release and taste-masking applications and can handle highly potent compounds. For biopharmaceuticals Hovione is investing by partnering in specialized particle engineering technologies, namely spray drying, aseptic spray freeze drying, nanoparticles and microemulsions. We do well what is difficult, to give our customers what they cannot find elsewhere
InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company specialized in the development and manufacturing of complex parenteral sustained release formulations. By using our proprietary biodegradable polymers we can make microspheres, erodible gels and solid implants resulting in long acting and minimally invasive drug delivery products of small, medium sized (peptides) and large (proteins, antibodies) drug molecules. We have state-of-the-art facilities for polymer R&D, formulation development, analytical characterization (GMP licensed), and manufacturing activities.
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill® (AP) platform technology. The Company’s Accordion Pill® is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism.
The AP is a unique delivery platform based on folded multilayer films. AP provides a better treatment through improving pharmacokinetics of drugs with narrow absorption windows or poor solubility. Furthermore, AP allows multiple drug release profiles in a single capsule and can provide fixed-dose combinations. Importantly, the AP safety and efficacy have been tested in more than 30 clinical studies, with more than tens of thousands of administrations. Intec holds several granted patent families that cover the AP technology.
Intertek Melbourn has specialist skills and experience in analytical testing and formulation for both small molecule and biologic orally inhaled and nasal drug products (OINDP), alongside all other pharmaceutical dosage forms. With 30 years of experience in supporting our clients’ inhaled and nasal product developments, we deliver world-class support for method development / validation, analytical testing, stability programs, CMC studies, formulation development and clinical manufacturing from our facility located in Melbourn, near Cambridge, UK. Our team of scientists have a reputation for providing outstanding and responsive customer service and we have recently announced a significant expansion to double our laboratory footprint and further increase our capacity and flexibility. Through our expertise in analytical and formulation support for the pharmaceutical, biotechnology and drug delivery industries, we help our clients to meet milestones for their challenging pharmaceutical development programmes. The laboratory is inspected and approved by the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for GMP compliance. The Laboratory has also been inspected by the US Food and Drug Administration (FDA) against GMP as part of clients’ pre-approval inspections.
LEUKOCARE AG, located in Martinsried, Germany, is a biotech company specialized in the field of formulation development. We develop superior formulations based on our pioneering SPS® formulation technology platform. The technology platform consists of two elements: a library of up to 100 different regulatory well-established and employed excipients and, moreover, a rational development approach which employs statistical software and self-learning algorithms as well as state of the art design of experiment (DoE) matrices. By utilizing these artificial intelligence elements, we are able to specifically combine excipients to generate tailored formulations that meet both the drug product requirements and needs of the relevant target product profile (TPP).
Our superior and innovative drug product formulations can be applied to a broad range of applications: biologics & biosimilars, vaccines & viral vectors and biofunctionalized devices.
Contact us at email@example.com
At Lonza Pharma & Biotech, we provide contract development and manufacturing services that enable pharma and biotech companies to bring medicines to patients in need. From the building blocks of life to the final drug product, our solutions are created to simplify your outsourcing experience and provide a reliable outcome, at the time when you expect it. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of biological and chemical drugs. We continuously invest to solve not just current, but also future challenges. Together, we can bring your next medicine to life.
LTS is the global leader in the development and manufacture of transdermal systems and oral thin films with additional innovative technologies in development. The products developed by LTS comprise a multitude of innovations, such as first and only patch for treatment of Alzheimer and the only patch against Parkinson’s and Restless-Legs-Syndrome, which is the first medication in the world available only as a patch. The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS supports its cooperation partners from product inception through commercialization in our FDA approved facilities in Germany and USA. More than 3,000 patents reinforce the top position of LTS group in development of its technologies. LTS Lohmann services include: Feasibility studies Full product development Clinical studies phase I-IV Scale-up and process development Commercial manufacturing For transdermal therapeutic systems, topical patches and oral thin films (OTF)
The Health business team at Lubrizol Life Science partners with customers to speed their innovative medical devices and differentiated pharmaceutical products to market. Our dedicated team provides best-in-class polymers and excipients, along with state-of-the-art product design, development, and manufacturing services, with the ultimate goal of creating solutions that improve patient outcomes. Driven by innovation, powered by partnership.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established R&D centres in the USA and UK and has its global HQ in Guildford, UK.
Merck KGaA, Darmstadt, Germany is a leading science and technology company in healthcare, life science and performance materials. We offer more than 400 pharmaceutical formulation raw materials for solid, liquid and semi-solid dosage forms, a wide range of active pharmaceutical ingredients and drug delivery compounds which include activated PEGs, lipids, PEG lipids for bioavailability enhancement. In addition, our Emprove® Program provides extensive regulatory documentation to facilitate risk assessment and qualification processes. Through dedicated collaboration on new scientific and engineering insights, we serve as a strategic partner to help advance the promise of life saving therapies. For more information on the company's portfolio, please click here.
MUNIT is a consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.
In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership in the micronization sector.
MUNIT is your access point to JETPHARMAs and MICROCHEMs services:
Nanoform is an innovative nanoparticle medicine-enabling company that works together with global Pharma and biotech partners to devise solutions to complex formulation challenges. Nanoform’s multi-patented and scalable Controlled Expansion of Supercritical Solutions (CESS®) process can produce uniform nanoparticles as small as 10nm, facilitating transport even across biological barriers. As particles smaller than 100nm have significantly enhanced surface areas, this can increase drug dissolution rates and improve bioavailability, allowing drugs of poor solubility in the pharmaceutical pipeline to progress to clinical development. CESS® enables lower dosage and safer products to be developed with reduced side-effects and permits combination therapies, which would otherwise be prohibited by the large dosages of either drug. The award-winning technology is also ushering in a new era of ocular, pulmonary and transdermal drug delivery applications, along with enhanced delivery of drug particles across the blood-brain barrier.
Nanomol Technologies, S.L. is a science and innovation driven company delivering advanced solutions and technologies to obtain high-added value products by particle design and nanoformulation, as well as advanced cGMP particle characterization services. DELOS is a sustainable proprietary formulation platform which improves the quality and performance of actives and ingredients. We develop next generation nanomedicines and new delivery systems with tailored and improved properties in terms of bioavailability, stability, addressability, and multifunctionality. DELOS protects and transports from small molecules to proteins and other biomolecules, integrating and stabilizing them on solid particles or nanovesicles.
PCI Pharma Services is an integrated full service provider offering unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch, delivering speed-to-market and commercial success for our customers. Our core services support each stage of the product lifecycle, including drug development, clinical trial supply, commercial launch and ongoing commercial supply. Customers can choose to use us as a complete development partner and benefit from our full range of services or choose any of our core services as a stand-alone offering. We partner with clients in providing innovative technologies, flexible solutions, and an integrated supply network supporting lifesaving medicines destined to over 100 countries around the world.
Pensatech Pharma GmbH is an innovative contract drug research and development company with a comprehensive suite of classical and innovative dosage form technologies. Our experience and solid understanding in product and process development helps our customers to overcome their drug delivery challenges in an efficient manner and turn ideas into robust innovative products. The focus of Pensatech Pharma’s services is the solution-oriented design and development of dosage forms for existing and new chemical entities as well as life-cycle management. Pensatech Pharma offers a wide range of drug delivery technologies especially with difficult-to-formulate drug molecules. We provide our customers various services that support the different product development' steps, including pre-formulation, formulation and process development activities, analytical method development and stability testing. Contact us (firstname.lastname@example.org) to discuss how our different services and experience could help you during the development of your product.
Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose and Ribose for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.
Pion is a science-based company providing innovative technology, solutions, support and scientific expertise to the drug development industry. Pion empowers the pharmaceutical research community to use trusted data for the development of new and unique products that make a difference to people’s lives.
For drug development scientists requiring trusted data, we provide novel in-vitro tools that promote quicker, more informed decision-making. Unlike conventional techniques, that were never designed for today’s science, Pion technologies lead to more predictable in-vivo outcomes.
Drug development can be a complex, multi-faceted challenge – so finding effective scientific support can be critical to making progress. More and more organizations are turning to Pion Analytical Services, for the tests, assays, analysis and interpretation required at all the key phases of drug development. As well as offering standardised assays our Scientists would love to talk to you about any other experiments you would like to run.
PMC Isochem offers contract research, custom manufacturing, catalogue products and innovative solutions for Pharmaceutical companies worldwide. Our offer addresses three major areas:
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Roquette is a global leader in plant-based ingredients and a pioneer of new vegetal proteins. In collaboration with its customers and partners, the Group addresses current and future societal challenges by unlocking the potential of Nature to offer the best ingredients for Food, Nutrition and Health markets. Each of these ingredients responds to unique and essential needs, and they enable healthier lifestyles. Thanks to a constant drive for innovation and a long-term vision, the Group is committed to improving the well-being of millions of people all over the world while taking care of resources and territories. Roquette currently operates in over 100 countries and employs 8,600 people worldwide.
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions that accelerate and increase the efficiency of drug discovery and materials design. Schrödinger has a growing pipeline of early-stage assets and has co-founded leading biotech companies, including Nimbus Therapeutics and Morphic Therapeutic. In addition, the company has deep partnerships and collaborations in such fields as biotechnology, pharmaceuticals, chemicals, and electronics. Through significant long-term investments in basic research, Schrödinger has made scientific breakthroughs across many areas of drug discovery and materials science. Founded in 1990, Schrödinger has nearly 400 employees and operations in the United States, Europe, Japan, and India, as well as business partners in China and Korea.
Sensile Medical develops on- and off-body worn liquid drug delivery devices. Our technology offers a highly customizable, safe and cost-efficient device platform for small and large volumes. The micro-infusion pumps enable highly precise dosing at variable delivery patterns and offer various opportunities to inject a drug without the need of changing the primary packaging. Our proficiencies range from design to industrialization including manufacturing, digital health solutions. The first pump for the treatment of Parkinson`s disease was launched by EVER Pharma in 2019. Sensile Medical is a Swiss company established in 2004 and a subsidiary of Gerresheimer AG since 2018.
Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients.
Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia. 3,200 collaborators and more than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.
Seqens’ R&D centers provide extensive expertise in tailor made-polymers design to meet our client’s needs. All our polymers are manufactured under GMP standards. Seqens’ technical and manufacturing teams have successfully completed countless cGMP medical-grade polymer synthesis projects, including: Drug delivery materials (functional excipients) and medical-grade materials (medical devices & therapeutics)
Shin-Etsu PFMD is the distribution organization of Shin-Etsu Chemical Co., Ltd. Japan and SE Tylose, Wiesbaden Germany and is registered in Wiesbaden. It is located at the Industrial Park Kalle-Albert in Wiesbaden. Together with our distributors, we are the exclusive business partners for our customers and multi national key accounts in the pharmaceutical- and the food industry. SE PFMD manages a regional, centralized warehouse for all products to be able to supply the customers in Europe on short-term base whenever necessary. SE PFMD will manage logistic for customers in other regions independent from Shin-Etsu´s production sites. For our pharma customers we offer with our technical application lab the possibility to optimize their processes if required. Our products are covering a very wide range of applications and they fully comply with FDA, USP/NF, JP and EP requirements. Pharmaceutical Excipients: Cellulose ether excipient is a pharmacologically inactive substance used as a carrier for the active ingredients in medication. PHARMACOAT® – Water-Soluble Film Coating Agent METOLOSE® – Binder and Thickening Agent METOLOSE® SR – Sustained release agent for hydrophilic matrix system L-HPC – Disintegrant with Binding Properties, Multifunctional Excipient HPMCP – Enteric Coating Agent Shin-Etsu AQOAT® – Enteric Coating Agent, Solid Dispersion Polymer Tylopur® – Low- and high viscosity Hypromellose
Our core competencies consist of design, development and production of mechatronic drive systems. Since 1936, our focus has been on innovation, best in class quality and service which is our key to success for worldwide OEM customers. Sonceboz is ISO 13485 certified and active in wearable drug delivery, medical devices and laboratory industry. Pharma companies looking for Large Volume Injectors for high viscosity drugs, Dual Cartridge or Auto-reconstitution Injectors will find interesting solutions in Sonceboz's new drug Delivery Device Platform. Customized technology modules like motor-drives, electronics, pumps and needle insertion systems are available for Medical device manufacturers. Address: Rue Rosselet Challandes - 5 2605 Sonceboz Switzerland
Stéarinerie Dubois is a French family-owned company established in 1820 and specializing in the production of GMP excipients for pharmaceutical, veterinary and life sciences markets.
Our lipid-based GMP excipients are used for oral, topical, rectal, vaginal and parenteral administration routes.
They are well known for their quality and their functionality: lubricants, taste-masking agents, bioavailability enhancers, sustained release vehicles, emulsifiers, solubilizers, thickeners and spreading agents.
Quality standards: IPEC-GMP, ISO 9001, ISO 14001, FSSC 22000, RSPO, GMP, Kosher.
Technobis Crystallization Systems is a world-leading technology provider for solid-state research, process development and formulation. Our mission is to make researchers all over the world more successful by providing smart and fast solutions, based on our unique technology, knowledge and expertise.
Our workflow consists:
The CrystalBreeder™ is the first crystallizer dedicated for both development and discovery, carrying out complete crystallization screens with as little as 1mg of sample.
The Crystal16® parallel crystallizer is a multiple reactor station providing a screening solution for solubility determination, solid-state research and process development: medium-throughput crystallization studies at a 1ml scale.
With 8 independently controlled reactors and additional analytical capabilities, the Crystalline™ is a unique modular product line at a working volume of 5 ml for solid-state research, process development and formulation research.
Upperton Pharma Solutions is an independent CDMO providing specialist Spray Drying and formulation services to the Pharmaceutical and Biotechnology industries. The company is a world-leader in Spray Drying technology, and offers a complete development package, from early stage feasibility studies and formulation development, to process optimisation, scale up and clinical trial (IMP) manufacturing, supporting a range of dosage forms. Comprehensive product testing and ICH stability studies are available through an extensive range of analytical capabilities.
Based in Nottingham, UK, and founded in 1999, our primary focus has always been on the versatile technology of Spray Drying and we have built up the expertise to support even the most challenging of molecules. The company has an extensive, multinational client-base, ranging from small start-ups to top pharma companies and we pride ourselves on our client-focused, flexible approach and scientific excellence.
ZERION has pioneered the patented Dispersome® technology that greatly enhances the solubility of poorly soluble drugs and improves bioavailability and therapeutic outcomes for the patients. The Dispersome® technology is based on preparing stable amorphous formulations by mixing high loads (more than 50% w/w) of the drug compound with whey protein, a by-product from cheese production. The Dispersome® technology has already proven its value in enabling the development of novel drug candidates. ZERION develops its own proprietary drug formulations and offers the Dispersome® technology to established pharma companies as a means to solve their most challenging drug solubility problems. ZERION was established in 2019 as a spinout from the University of Copenhagen based on almost a decade of research